fda remove semaglutide from shortage list As of February 21, 2025, the updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A The FDA says it's standing

Diabetics who use GLP-1s tend to secrete more insulin to lower their blood sugar, further inflaming the pancreas and resulting in pancreatitis

A Framework for the Decision The choice between semaglutide and tirzepatide is a clinical decision made with a physician

The dual action of tirzepatide might help overcome plateaus experienced with semaglutide

With our expert medical guidance, you can get to the root of hormonal imbalances contributing to your symptoms and start looking and feeling like your younger self again

Symptoms that you may experience are: Sweating Shaking Hunger Dizziness Blurred vision Confusion Fast heartbeat Some patients may need to reduce the dose of their insulin after they start Wegovy

Our patient-first approach eases the process and builds confidence